Milestone Pharmaceuticals MIST
NASDAQ MIST
$1.05 -0.02 (-1.87%)
At close: Sep 10, 2026 · 4:00 PM EDT

Milestone Pharmaceuticals (MIST) Treasury Shares (2018 - 2019)

Milestone Pharmaceuticals' (MIST) quarterly Treasury Shares came in at -$6.9 million in Q2 2019, down 282.03% on a YoY basis from $3.8 million in Q2 2018, and down 200.0% quarter-over-quarter from $6.9 million in Q1 2019.

Analysis

Milestone Pharmaceuticals (MIST) Treasury Shares (2018 - 2019) Analysis & Trends

Milestone Pharmaceuticals (MIST) has reported Treasury Shares for 2 consecutive years, with -$6.9 million the latest figure, recorded in Q2 2019.

  • For the quarter ending Q2 2019, Treasury Shares fell 282.03% year-over-year to -$6.9 million; the trailing twelve-month figure through Jun 2019 stood at -$6.9 million (down 282.03% YoY), and the FY2018 full-year result was $6.9 million, changed N/A from the prior year.
  • Treasury Shares eased to -$6.9 million in Q2 2019 per MIST's latest filing, from $6.9 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $6.9 million in Q4 2018 and bottomed at -$6.9 million in Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 36.40 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -23.80 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Milestone Pharmaceuticals 146.32 Mn -25.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 -6.89 Mn
Jun 30, 2019 -6.89 Mn
Mar 31, 2019 6.89 Mn
Mar 31, 2019 6.89 Mn
Dec 31, 2018 6.89 Mn
Dec 31, 2018 6.89 Mn
Sep 30, 2018 3.79 Mn
Sep 30, 2018 3.79 Mn
Jun 30, 2018 3.79 Mn
Jun 30, 2018 3.79 Mn
Mar 31, 2018 3.79 Mn
Mar 31, 2018 3.79 Mn